CIK 1389933
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 60.20% | 55 |
| Unclassified | 20.88% | 12 |
| Health Care Equipment & Supplies | 18.92% | 15 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | Health Care | 13.02% |
| 2 | XBI | SPDR SERIES TRUST | Unclassified | 9.38% |
| 3 | STXS | Stereotaxis, Inc. | Health Care | 5.80% |
| 4 | DAY ONE BIOPHARMACEUTICALS I | Unclassified | 4.84% | |
| 5 | ATRC | AtriCure, Inc. | Health Care | 3.93% |
| 6 | IDYA | IDEAYA Biosciences, Inc. | Health Care | 3.66% |
| 7 | XENE | Xenon Pharmaceuticals Inc. | Health Care | 3.36% |
| 8 | CYTK | CYTOKINETICS INC | Health Care | 3.31% |
| 9 | CMPS | COMPASS Pathways plc | Health Care | 3.08% |
| 10 | NKTR | NEKTAR THERAPEUTICS | Health Care | 2.74% |
70/82 names classified · sector 79.1% of weight · industry 79.1% · mkt cap 77.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 79.1% of the book is sector-classified (unclassified names shown, never dropped).
Only 13% of book weight classified — the grid is NOT representative of the whole book.
Classified: 12.6% of book weight (8/80 names) · unclassified 87.4%: RVMD, XBI, , ATRC, IDYA, XENE, CYTK, CMPS, NKTR, IBB +62 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 580,678 | $56M | 13.0% | TRIM −4% |
| 2 | XBISPDR SERIES TRUST | 318,505 | $41M | 9.4% | TRIM −5% |
| 3 | STXSSTEREOTAXIS INC | 13,680,554 | $25M | 5.8% | HOLD |
| 4 | DAY ONE BIOPHARMACEUTICALS I | 978,463 | $21M | 4.8% | TRIM −2% |
| 5 | ATRCATRICURE INC | 597,431 | $17M | 3.9% | HOLD |
| 6 | IDYAIDEAYA BIOSCIENCES INC | 476,740 | $16M | 3.7% | TRIM −6% |
| 7 | XENEXENON PHARMACEUTICALS INC | 250,772 | $15M | 3.4% | TRIM −13% |
| 8 | CYTKCYTOKINETICS INC | 217,497 | $14M | 3.3% | TRIM −41% |
| 9 | CMPSCOMPASS PATHWAYS PLC | 2,418,882 | $13M | 3.1% | ADD 198% |
| 10 | NKTRNEKTAR THERAPEUTICS | 165,178 | $12M | 2.7% | ADD 120% |
| 11 | IBBISHARES TR | 62,095 | $10M | 2.4% | TRIM −9% |
| 12 | RCUSARCUS BIOSCIENCES INC | 443,829 | $10M | 2.2% | ADD 3% |
| 13 | NBIXNEUROCRINE BIOSCIENCES INC | 70,615 | $9M | 2.1% | HOLD |
| 14 | LRMRLARIMAR THERAPEUTICS INC | 2,029,164 | $9M | 2.1% | ADD 116% |
| 15 | BCAXBICARA THERAPEUTICS INC | 421,733 | $8M | 1.9% | ADD 61% |
| 16 | AXGNAXOGEN INC | 249,960 | $8M | 1.9% | TRIM −48% |
| 17 | BHVNBIOHAVEN LTD | 845,735 | $7M | 1.6% | TRIM −11% |
| 18 | TNDMTANDEM DIABETES CARE INC | 355,208 | $7M | 1.6% | HOLD |
| 19 | DNLIDENALI THERAPEUTICS INC | 318,500 | $6M | 1.4% | HOLD |
| 20 | IPSCCENTURY THERAPEUTICS INC | 2,434,353 | $6M | 1.3% | TRIM −13% |
| 21 | DXCMDEXCOM | 86,279 | $5M | 1.2% | TRIM −2% |
| 22 | KALVISTA PHARMACEUTICALS INC | 267,402 | $5M | 1.2% | TRIM −25% |
| 23 | ASNDASCENDIS PHARMA A/S | 23,177 | $5M | 1.2% | TRIM −18% |
| 24 | MBXMBX BIOSCIENCES INC | 175,465 | $5M | 1.2% | ADD 6% |
| 25 | INGNINOGEN INC | 845,179 | $5M | 1.2% | ADD 2% |
| 26 | SNDXSYNDAX PHARMACEUTICALS INC | 217,355 | $5M | 1.2% | TRIM −22% |
| 27 | ALKSALKERMES PLC | 139,482 | $5M | 1.1% | ADD 7% |
| 28 | STOKSTOKE THERAPEUTICS INC | 130,875 | $4M | 1.0% | ADD 20% |
| 29 | BCRXBIOCRYST PHARMACEUTICALS INC | 430,248 | $4M | 0.9% | ADD 3% |
| 30 | LKFTGALAPAGOS NV | 130,175 | $4M | 0.9% | HOLD |
| 31 | IMVTIMMUNOVANT INC | 150,524 | $4M | 0.9% | HOLD |
| 32 | EWTXEDGEWISE THERAPEUTICS INC | 112,236 | $4M | 0.8% | TRIM −30% |
| 33 | MPLTMAPLIGHT THERAPEUTICS INC | 171,006 | $3M | 0.8% | ADD 19% |
| 34 | ALLOALLOGENE THERAPEUTICS INC | 1,370,118 | $3M | 0.8% | HOLD |
| 35 | PRCTPROCEPT BIOROBOTICS CORP | 120,000 | $3M | 0.7% | HOLD |
| 36 | ALGNALIGN TECHNOLOGY INC | 15,000 | $3M | 0.6% | TRIM −6% |
| 37 | PRQRPROQR THRAPEUTICS N V | 1,567,561 | $3M | 0.6% | HOLD |
| 38 | HELPCYBIN INC | 498,361 | $2M | 0.6% | ADD 10% |
| 39 | RAPPRAPPORT THERAPEUTICS INC | 75,000 | $2M | 0.5% | HOLD |
| 40 | PODDINSULET CORP | 10,870 | $2M | 0.5% | ADD 58% |
| 41 | GPCRSTRUCTURE THERAPEUTICS INC | 46,500 | $2M | 0.5% | ADD 26% |
| 42 | IMTXIMMATICS N.V | 225,860 | $2M | 0.5% | TRIM −14% |
| 43 | CLDXCELLDEX THERAPEUTICS INC NEW | 68,518 | $2M | 0.5% | HOLD |
| 44 | LXEOLEXEO THERAPEUTICS INC | 377,059 | $2M | 0.5% | ADD 11% |
| 45 | ALECALECTOR INC | 908,351 | $2M | 0.5% | HOLD |
| 46 | VKTXVIKING THERAPEUTICS INC | 59,516 | $2M | 0.4% | HOLD |
| 47 | KURAKURA ONCOLOGY INC | 235,868 | $2M | 0.4% | HOLD |
| 48 | PROFPROFOUND MED CORP | 263,005 | $2M | 0.4% | TRIM −8% |
| 49 | FULCFULCRUM THERAPEUTICS INC | 205,000 | $2M | 0.4% | NEW |
| 50 | AQSTAQUESTIVE THERAPEUTICS INC | 368,415 | $2M | 0.4% | HOLD |
| 51 | MDWDMEDIWOUND LTD | 94,405 | $2M | 0.4% | TRIM −17% |
| 52 | KIDSORTHOPEDIATRICS CORP | 95,659 | $2M | 0.4% | NEW |
| 53 | RAREULTRAGENYX PHARMACEUTICAL IN | 61,100 | $1M | 0.3% | ADD 282% |
| 54 | ENGENE HOLDINGS INC | 187,353 | $1M | 0.3% | ADD 14% |
| 55 | NGNENEUROGENE INC | 56,635 | $1M | 0.3% | ADD 102% |
| 56 | SPRYARS PHARMACEUTICALS INC | 139,285 | $1M | 0.3% | TRIM −27% |
| 57 | CTMXCYTOMX THERAPEUTICS INC. | 230,000 | $1M | 0.2% | NEW |
| 58 | MAZEMAZE THERAPEUTICS INC | 35,000 | $1M | 0.2% | NEW |
| 59 | MLYSMINERALYS THERAPEUTICS INC | 38,490 | $1M | 0.2% | HOLD |
| 60 | SCYXSCYNEXIS INC | 1,086,956 | $996,630 | 0.2% | NEW |
| 61 | ORICORIC PHARMACEUTICALS INC | 98,724 | $945,460 | 0.2% | TRIM −30% |
| 62 | INSPINSPIRE MED SYS INC | 18,200 | $938,756 | 0.2% | ADD 112% |
| 63 | PYPDPOLYPID LTD | 207,900 | $910,602 | 0.2% | HOLD |
| 64 | TELATELA BIO INC | 1,441,029 | $893,438 | 0.2% | HOLD |
| 65 | ZBIOZENAS BIOPHARMA INC | 42,500 | $830,875 | 0.2% | NEW |
| 66 | VRCAVERRICA PHARMACEUTICALS INC | 153,712 | $813,136 | 0.2% | TRIM −11% |
| 67 | FATEFATE THERAPEUTICS INC | 550,000 | $660,000 | 0.2% | HOLD |
| 68 | ANNXANNEXON INC | 117,812 | $652,678 | 0.2% | TRIM −57% |
| 69 | ARAYACCURAY INC | 1,680,508 | $652,205 | 0.2% | ADD 20% |
| 70 | NAMSNEWAMSTERDAM PHARMA COMPANY | 20,000 | $640,200 | 0.1% | NEW |
| 71 | ACETADICET BIO INC | 93,812 | $638,860 | 0.1% | HOLD |
| 72 | BNTXBIONTECH SE | 7,000 | $622,160 | 0.1% | HOLD |
| 73 | PLRXPLIANT THERAPEUTICS INC | 487,000 | $613,620 | 0.1% | NEW |
| 74 | CGENCOMPUGEN LTD | 257,783 | $549,078 | 0.1% | TRIM −5% |
| 75 | OBIOORCHESTRA BIOMED HLDGS INC | 126,841 | $539,074 | 0.1% | HOLD |
| 76 | FHTXFOGHORN THERAPEUTICS INC | 111,859 | $534,686 | 0.1% | TRIM −12% |
| 77 | IBIOIBIO INC | 193,638 | $367,912 | 0.1% | NEW |
| 78 | BCYCBICYCLE THERAPEUTICS PLC | 64,492 | $299,243 | 0.1% | HOLD |
| 79 | ADCTADC THERAPEUTICS SA | 72,081 | $270,304 | 0.1% | TRIM −6% |
| 80 | KPTIKARYOPHARM THERAPEUTICS INC | 45,800 | $255,106 | 0.1% | TRIM −10% |
| 81 | AUTLAUTOLUS THERAPEUTICS PLC | 179,316 | $247,456 | 0.1% | HOLD |
| 82 | NMRANEUMORA THERAPEUTICS INC. | 70,000 | $136,500 | 0.0% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| RVMDREVOLUTION MEDICINES INC | 631K | 656K | 677K | 657K | 605K | 581K | $56M |
| XBISPDR SERIES TRUST | 398K | 405K | 416K | 402K | 337K | 319K | $41M |
| STXSSTEREOTAXIS INC | 13.7M | 13.7M | 13.7M | 13.7M | 13.7M | 13.7M | $25M |
| DAY ONE BIOPHARMACEUTICALS I | 731K | 731K | 879K | 999K | 999K | 978K | $21M |
| ATRCATRICURE INC | 642K | 592K | 592K | 592K | 597K | 597K | $17M |
| IDYAIDEAYA BIOSCIENCES INC | 499K | 589K | 619K | 540K | 507K | 477K | $16M |
| XENEXENON PHARMACEUTICALS INC | 274K | 274K | 288K | 288K | 288K | 251K | $15M |
| CYTKCYTOKINETICS INC | 398K | 398K | 398K | 395K | 371K | 217K | $14M |
| CMPSCOMPASS PATHWAYS PLC | 243K | 711K | 811K | 811K | 811K | 2.4M | $13M |
| NKTRNEKTAR THERAPEUTICS | — | — | 10K | 55K | 75K | 165K | $12M |
| IBBISHARES TR | 103K | 103K | 103K | 103K | 68K | 62K | $10M |
| RCUSARCUS BIOSCIENCES INC | 254K | 625K | 628K | 628K | 431K | 444K | $10M |
| NBIXNEUROCRINE BIOSCIENCES INC | 72K | 72K | 71K | 71K | 71K | 71K | $9M |
| LRMRLARIMAR THERAPEUTICS INC | 371K | 371K | 371K | 1.0M | 939K | 2.0M | $9M |
| BCAXBICARA THERAPEUTICS INC | 106K | 212K | 317K | 317K | 262K | 422K | $8M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
